ID: ALA1908024

Max Phase: Preclinical

Molecular Formula: C12H12N2O4

Molecular Weight: 248.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC1(c2ccc(O)cc2)C(=O)NC(=O)NC1=O

Standard InChI:  InChI=1S/C12H12N2O4/c1-2-12(7-3-5-8(15)6-4-7)9(16)13-11(18)14-10(12)17/h3-6,15H,2H2,1H3,(H2,13,14,16,17,18)

Standard InChI Key:  IEPXMKJNWPXDBP-UHFFFAOYSA-N

Associated Targets(Human)

UDP-glucuronosyltransferase 2B7 787 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.24Molecular Weight (Monoisotopic): 248.0797AlogP: 0.41#Rotatable Bonds: 2
Polar Surface Area: 95.50Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.13CX Basic pKa: CX LogP: 1.10CX LogD: 0.66
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.66Np Likeness Score: 0.42

References

1. Tukey RH, Strassburg CP..  (2000)  Human UDP-glucuronosyltransferases: metabolism, expression, and disease.,  40  (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581]
2.  (1999)  Therapeutic Drugs,